$OPCH
Option Care Health, Inc.

2018 Q1 Form 10-Q Financial Statement

#000162828018006458 Filed on May 10, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $168.6M $217.8M
YoY Change -22.6% -8.66%
Cost Of Revenue $113.5M $152.9M
YoY Change -25.76% -12.22%
Gross Profit $101.7M $64.87M
YoY Change 56.76% 2.48%
Gross Profit Margin 60.32% 29.78%
Selling, General & Admin $10.70M $16.30M
YoY Change -34.36% -12.37%
% of Gross Profit 10.52% 25.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.486M $7.165M
YoY Change -9.48% 57.89%
% of Gross Profit 6.38% 11.04%
Operating Expenses $58.34M $67.90M
YoY Change -14.09% 8.12%
Operating Profit $3.065M -$3.026M
YoY Change -201.29% 137.71%
Interest Expense -$13.40M -$12.70M
YoY Change 5.47% 35.11%
% of Operating Profit -437.03%
Other Income/Expense, Net -$9.651M
YoY Change
Pretax Income -$12.94M -$18.80M
YoY Change -31.18% 82.34%
Income Tax $48.00K $619.0K
% Of Pretax Income
Net Earnings -$6.851M -$19.72M
YoY Change -65.26% 100.6%
Net Earnings / Revenue -4.06% -9.05%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.15 -$663.3K
COMMON SHARES
Basic Shares Outstanding 127.8M shares 121.0M shares
Diluted Shares Outstanding 130.4M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.40M $16.00M
YoY Change 90.0% 97.53%
Cash & Equivalents $30.35M $15.97M
Short-Term Investments
Other Short-Term Assets $15.80M $20.00M
YoY Change -21.0% 0.5%
Inventory $41.55M $30.55M
Prepaid Expenses
Receivables $88.20M $109.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $176.0M $176.0M
YoY Change -0.04% 10.81%
LONG-TERM ASSETS
Property, Plant & Equipment $24.97M $30.42M
YoY Change -17.9% -0.22%
Goodwill $367.2M $365.9M
YoY Change 0.34% 18.53%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.082M $2.173M
YoY Change -4.19% 92.3%
Total Long-Term Assets $410.9M $426.4M
YoY Change -3.63% 23.72%
TOTAL ASSETS
Total Short-Term Assets $176.0M $176.0M
Total Long-Term Assets $410.9M $426.4M
Total Assets $586.9M $602.4M
YoY Change -2.58% 19.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $68.84M $47.45M
YoY Change 45.08% -10.62%
Accrued Expenses $30.20M $47.40M
YoY Change -36.29% 1.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.100M $22.40M
YoY Change -95.09% -30.43%
Total Short-Term Liabilities $103.7M $121.7M
YoY Change -14.82% -10.29%
LONG-TERM LIABILITIES
Long-Term Debt $480.4M $450.1M
YoY Change 6.73% 14.91%
Other Long-Term Liabilities $18.28M $1.180M
YoY Change 1449.32% -43.78%
Total Long-Term Liabilities $18.28M $1.180M
YoY Change 1449.32% -43.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.7M $121.7M
Total Long-Term Liabilities $18.28M $1.180M
Total Liabilities $602.4M $575.9M
YoY Change 4.6% 8.67%
SHAREHOLDERS EQUITY
Retained Earnings -$722.5M -$662.8M
YoY Change 9.0% 8.41%
Common Stock $622.7M $615.0M
YoY Change 1.25% 15.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $354.0K
YoY Change
Treasury Stock Shares 96.47K shares
Shareholders Equity $600.7M -$47.86M
YoY Change
Total Liabilities & Shareholders Equity $586.9M $602.4M
YoY Change -2.58% 19.65%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$6.851M -$19.72M
YoY Change -65.26% 100.6%
Depreciation, Depletion And Amortization $6.486M $7.165M
YoY Change -9.48% 57.89%
Cash From Operating Activities -$5.192M -$11.03M
YoY Change -52.94% 0.64%
INVESTING ACTIVITIES
Capital Expenditures $2.646M $1.684M
YoY Change 57.13% -30.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.646M -$1.684M
YoY Change 57.13% 27.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.052M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.267M $24.25M
YoY Change -105.22% 409.54%
NET CHANGE
Cash From Operating Activities -$5.192M -$11.03M
Cash From Investing Activities -$2.646M -$1.684M
Cash From Financing Activities -$1.267M $24.25M
Net Change In Cash -$9.105M $11.53M
YoY Change -178.95% -253.19%
FREE CASH FLOW
Cash From Operating Activities -$5.192M -$11.03M
Capital Expenditures $2.646M $1.684M
Free Cash Flow -$7.838M -$12.72M
YoY Change -38.37% -5.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
26118000 USD
CY2018Q1 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
27933000 USD
CY2017Q1 bios Acquisition Integration Restructuringand Other Expenses
AcquisitionIntegrationRestructuringandOtherExpenses
3223000 USD
CY2018Q1 bios Acquisition Integration Restructuringand Other Expenses
AcquisitionIntegrationRestructuringandOtherExpenses
1882000 USD
CY2017Q4 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
4621000 USD
CY2018Q1 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
3652000 USD
CY2018Q1 bios Debt And Warrants Outstanding
DebtAndWarrantsOutstanding
500122000 USD
CY2017Q1 bios Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount
0 USD
CY2018Q1 bios Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount
0 USD
CY2017Q1 bios Gain Losson Dispositionof Property Plant Equipment1
GainLossonDispositionofPropertyPlantEquipment1
0 USD
CY2018Q1 bios Gain Losson Dispositionof Property Plant Equipment1
GainLossonDispositionofPropertyPlantEquipment1
305000 USD
CY2017Q1 bios Increase Decreasein Amounts Due To Plan Sponsor
IncreaseDecreaseinAmountsDueToPlanSponsor
645000 USD
CY2018Q1 bios Increase Decreasein Amounts Due To Plan Sponsor
IncreaseDecreaseinAmountsDueToPlanSponsor
-969000 USD
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127951915 shares
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
BioScrip, Inc.
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
65963000 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
68835000 USD
CY2017Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
123434000 USD
CY2018Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
88185000 USD
CY2017Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
85522000 USD
CY2018Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
88185000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
624762000 USD
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
622657000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
37912000 USD
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
37912000 USD
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
USD
CY2017Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1318000 USD
CY2018Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2023000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7165000 USD
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6486000 USD
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19400000 shares
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18800000 shares
CY2017Q4 us-gaap Assets
Assets
603092000 USD
CY2018Q1 us-gaap Assets
Assets
586882000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
187691000 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
175950000 USD
CY2017Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
17000 USD
CY2018Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
3000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39457000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30352000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11532000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9105000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9569000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21101000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44407000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35302000 USD
CY2017Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-299000 USD
CY2018Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-30000 USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127634012 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127793785 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127634012 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127793785 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
152936000 USD
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
113536000 USD
CY2017Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2018Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2017Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2018Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17000 USD
CY2017Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2018Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
17000 USD
CY2017Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
495000 USD
CY2018Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2017Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3656000 USD
CY2018Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3318000 USD
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
619000 USD
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
31000 USD
CY2017Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
124000 USD
CY2018Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
31000 USD
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1098000 USD
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1066000 USD
CY2018Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
11500000 USD
CY2017Q1 us-gaap Depreciation
Depreciation
7165000 USD
CY2018Q1 us-gaap Depreciation
Depreciation
6486000 USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19114000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16681000 USD
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2018Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
305000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9266000 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10669000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
367198000 USD
CY2018Q1 us-gaap Goodwill
Goodwill
367198000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
64874000 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
55048000 USD
CY2017Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
217810000 USD
CY2018Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
168584000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-19419000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-12987000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18800000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12939000 USD
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-299000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.18
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.12
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6706000 USD
CY2018Q1 us-gaap Interest Payable Current
InterestPayableCurrent
2219000 USD
CY2018Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2729000 USD
CY2017Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
52000 USD
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-30000 USD
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3439000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
619000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000 USD
CY2017Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6976000 USD
CY2018Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3419000 USD
CY2017Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6445000 USD
CY2018Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-690000 USD
CY2017Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
36000 USD
CY2018Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
48000 USD
CY2017Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
125000 USD
CY2018Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-82000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-10936000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2872000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-619000 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-31000 USD
CY2017Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1157000 USD
CY2018Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-4487000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5616000 USD
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3505000 USD
CY2017Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-917000 USD
CY2018Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2418000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3601000 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8807000 USD
CY2017Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2210000 USD
CY2018Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2663000 USD
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12659000 USD
CY2018Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13395000 USD
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
12548000 USD
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
15883000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
38044000 USD
CY2018Q1 us-gaap Inventory Net
InventoryNet
41549000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
605765000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
602358000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
603092000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
586882000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
105130000 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
103694000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5162000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5192000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10734000 USD
CY2017Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
23060000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
478866000 USD
CY2018Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
480382000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1722000 USD
CY2018Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1055000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
480588000 USD
CY2018Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
481437000 USD
CY2017Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
0 USD
CY2018Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
3439000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24249000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1267000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1684000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2646000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11033000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-19718000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-13017000 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22106000 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15674000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2116000 USD
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2082000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21769000 USD
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18282000 USD
CY2017Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
44319000 USD
CY2018Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
39299000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1684000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2646000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18620000 USD
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9848000 USD
CY2018Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5052000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2017Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
563000 USD
CY2018Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2017Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-51000 USD
CY2018Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-300000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26973000 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24971000 USD
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7042000 USD
CY2018Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
85522000 USD
CY2018Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
88185000 USD
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
238000 USD
CY2018Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
967000 USD
CY2017Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1000000 USD
CY2018Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
CY2017Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
3137000 USD
CY2018Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4950000 USD
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4950000 USD
CY2017Q1 us-gaap Restructuring Charges
RestructuringCharges
3206000 USD
CY2018Q1 us-gaap Restructuring Charges
RestructuringCharges
1879000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-709511000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-722528000 USD
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168584000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
521000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
556000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-84752000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-100212000 USD
CY2017Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
174000 USD
CY2018Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
176000 USD
CY2017Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
2214000 USD
CY2018Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
2481000 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5106 shares
CY2018Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
96467 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
16000 USD
CY2018Q1 us-gaap Treasury Stock Value
TreasuryStockValue
354000 USD
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
118783000 shares
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
127772000 shares

Files In Submission

Name View Source Status
0001628280-18-006458-index-headers.html Edgar Link pending
0001628280-18-006458-index.html Edgar Link pending
0001628280-18-006458.txt Edgar Link pending
0001628280-18-006458-xbrl.zip Edgar Link pending
bios-20180331.xml Edgar Link completed
bios-20180331.xsd Edgar Link pending
bios-20180331x10q.htm Edgar Link pending
bios-20180331_cal.xml Edgar Link unprocessable
bios-20180331_def.xml Edgar Link unprocessable
bios-20180331_lab.xml Edgar Link unprocessable
bios-20180331_pre.xml Edgar Link unprocessable
bios-ex311x20180331x10q.htm Edgar Link pending
bios-ex312x20180331x10q.htm Edgar Link pending
bios-ex321x20180331x10q.htm Edgar Link pending
bios-ex322x20180331x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logowithregisteredtm07.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending